InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Cohen Fred E, Director. Officer active across 3 companies, notably CareDx, Inc.. In total, 8 disclosures have been published. The latest transaction was filed on 16 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations8 total
04,863 shares0
Common Stock
SEC:0001217234-22-000125:0·
05,197 shares0
Common Stock
SEC:0001209191-22-037590:0·
02,652 shares0
Common Stock
SEC:0001179110-21-009630·
02,652 shares0
Common Stock
SEC:0001179110-21-009630:0·
02,094 shares0
Common Stock
SEC:0001209191-21-043362·
02,094 shares0
Common Stock
SEC:0001209191-21-043362:0·
01,127 shares0
Common Stock
SEC:0001217234-21-000140·
01,127 shares0
Common Stock
SEC:0001217234-21-000140:0·
8 of 8 declarations
About Cohen Fred E
Fred E. Cohen is a Director at CareDx, Inc., Intellia Therapeutics, Inc., and Progyny, Inc. As a board member, he plays a key role in the governance of these companies and in shaping their strategy. His expertise in the healthcare sector and management experience contribute to performance evaluation and guiding policies.
